US Moves to Turn Most Favored Nation Drug Pricing Policy Into Law
Director of Medicare and Deputy Administrator of CMS Chris Klomp speaks after U.S. President Donald Trump announced a deal with Pfizer to sell drugs at lower prices, in the Oval office of the White House in Washington on Sept. 30, 2025. Ken Cedeno/Reuters The U.S. government has begun talks with pharmaceutical companies to turn President